19-11397521-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001035223.4(RGL3):c.1823C>T(p.Ala608Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000205 in 1,613,228 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001035223.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RGL3 | NM_001035223.4 | c.1823C>T | p.Ala608Val | missense_variant | 17/19 | ENST00000380456.8 | NP_001030300.3 | |
RGL3 | NM_001161616.3 | c.1841C>T | p.Ala614Val | missense_variant | 17/19 | NP_001155088.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RGL3 | ENST00000380456.8 | c.1823C>T | p.Ala608Val | missense_variant | 17/19 | 1 | NM_001035223.4 | ENSP00000369823 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152184Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000808 AC: 2AN: 247430Hom.: 0 AF XY: 0.0000149 AC XY: 2AN XY: 134662
GnomAD4 exome AF: 0.0000219 AC: 32AN: 1461044Hom.: 0 Cov.: 31 AF XY: 0.0000248 AC XY: 18AN XY: 726824
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152184Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74354
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 03, 2023 | The c.1841C>T (p.A614V) alteration is located in exon 17 (coding exon 17) of the RGL3 gene. This alteration results from a C to T substitution at nucleotide position 1841, causing the alanine (A) at amino acid position 614 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at